This biosensor was tested and validated for reliable performance via the detection and analysis of the activation level of caspase-3 in cancer cells with label-free and high-throughput features, which can be used to monitor and assess apoptosis induction by anti-cancer drugs treatment at the molecular level. This evidence concerns the gene CASP3 and cancer.